Viewing StudyNCT00312039



Ignite Creation Date: 2024-05-05 @ 4:47 PM
Last Modification Date: 2024-10-26 @ 9:24 AM
Study NCT ID: NCT00312039
Status: COMPLETED
Last Update Posted: 2023-08-25
First Post: 2006-04-05

Brief Title: Study of Once Daily Elvucitabine Versus Lamivudine in Participants With a Documented M184V Mutation
Sponsor:
Organization: Alexion Pharmaceuticals Inc